While Humana Inc has overperformed by 3.83%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HUM rose by 5.04%, with highs and lows ranging from $315.35 to $206.87, whereas the simple moving average jumped by 3.04% in the last 200 days.
On December 05, 2025, Jefferies Upgraded Humana Inc (NYSE: HUM) to Buy. A report published by Goldman on October 14, 2025, Initiated its previous ‘Sell’ rating for HUM. Evercore ISI also rated HUM shares as ‘In-line’, setting a target price of $295 on the company’s shares in an initiating report dated September 22, 2025. BofA Securities November 06, 2024d its ‘Underperform’ rating to ‘Neutral’ for HUM, as published in its report on November 06, 2024. Bernstein also rated the stock as ‘Outperform’.
Analysis of Humana Inc (HUM)
A return on investment can be expected regardless of HUM’s performance over the next quarter with the dividend set at $3.54 per share. Further, the quarter-over-quarter increase in sales is 11.06%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Humana Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of 7.15% is sufficient for you to turn a profit off your investment.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and HUM is recording an average volume of 1.81M. On a monthly basis, the volatility of the stock is set at 3.65%, whereas on a weekly basis, it is put at 3.91%, with a gain of 5.32% over the past seven days. Furthermore, long-term investors anticipate a median target price of $285.75, showing growth from the present price of $266.49, which can serve as yet another indication of whether HUM is worth investing in or should be passed over.
How Do You Analyze Humana Inc Shares?
A leading company in the Healthcare Plans sector, Humana Inc (HUM) is based in the USA. When comparing Humana Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 24.98, there is a growth in quarterly earnings of -59.37%.
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.22%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 96.80% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
HUM shares are owned by institutional investors to the tune of 96.80% at present.
